BACKGROUND AND PURPOSE: EnF is a newly described measure of proportional tumor enhancement derived from DCE-MR imaging. The aim of this study was to assess the relationship between EnF and the more established DCE-MR imaging parameters: K(trans), v(e), and v(p). MATERIALS AND METHODS: Forty-two patients with 43 gliomas (16 grade II, 3 grade III, and 24 grade IV) were studied. Imaging included pre- and postcontrast T1-weighted sequences through the lesion and T1-weighted DCE-MR imaging. Parametric maps of EnF, K(trans), v(e), and v(p) were generated. Voxels were classified as enhancing if the IAUC was positive (EnF(IAUC)(60>0)). A threshold of IAUC > 2.5 mmol.s was used to generate EnF(IAUC)(60>2.5). Both measures of EnF were compared with the DCE-MR imaging parameters (K(trans), v(e), and v(p)). RESULTS: In grade II gliomas, EnF(IAUC60>0) and EnF(IAUC60>2.5) correlated with v(p) (R(2) = 0.6245, P < .0005; and R(2) = 0.4727, P = .003) but not with K(trans) or v(e). In grade IV tumors, both EnF(IAUC60>0) and EnF(IAUC60>2.5) correlated with K(trans) (R(2) = 0.3501, P = .001; and R(2) = 0.4699, P < .0005) and v(p) (R(2) = 0.1564, P = .01; and R(2) = 0.2429, P = .007), but not with v(e). Multiple regression analysis showed K(trans) as the only independent correlate of both EnF(IAUC60>0) and EnF(IAUC60>2.5) for grade IV tumors. CONCLUSIONS: This study suggests that in grade II tumors, EnF reflects v(p) and varies due to changes in vascular density. In grade IV gliomas, EnF is affected by K(trans) with secondary associated changes in v(p).
BACKGROUND AND PURPOSE: EnF is a newly described measure of proportional tumor enhancement derived from DCE-MR imaging. The aim of this study was to assess the relationship between EnF and the more established DCE-MR imaging parameters: K(trans), v(e), and v(p). MATERIALS AND METHODS: Forty-two patients with 43 gliomas (16 grade II, 3 grade III, and 24 grade IV) were studied. Imaging included pre- and postcontrast T1-weighted sequences through the lesion and T1-weighted DCE-MR imaging. Parametric maps of EnF, K(trans), v(e), and v(p) were generated. Voxels were classified as enhancing if the IAUC was positive (EnF(IAUC)(60>0)). A threshold of IAUC > 2.5 mmol.s was used to generate EnF(IAUC)(60>2.5). Both measures of EnF were compared with the DCE-MR imaging parameters (K(trans), v(e), and v(p)). RESULTS: In grade II gliomas, EnF(IAUC60>0) and EnF(IAUC60>2.5) correlated with v(p) (R(2) = 0.6245, P < .0005; and R(2) = 0.4727, P = .003) but not with K(trans) or v(e). In grade IV tumors, both EnF(IAUC60>0) and EnF(IAUC60>2.5) correlated with K(trans) (R(2) = 0.3501, P = .001; and R(2) = 0.4699, P < .0005) and v(p) (R(2) = 0.1564, P = .01; and R(2) = 0.2429, P = .007), but not with v(e). Multiple regression analysis showed K(trans) as the only independent correlate of both EnF(IAUC60>0) and EnF(IAUC60>2.5) for grade IV tumors. CONCLUSIONS: This study suggests that in grade II tumors, EnF reflects v(p) and varies due to changes in vascular density. In grade IV gliomas, EnF is affected by K(trans) with secondary associated changes in v(p).
Authors: Yue Cao; Christina I Tsien; Vijaya Nagesh; Larry Junck; Randall Ten Haken; Brian D Ross; Thomas L Chenevert; Theodore S Lawrence Journal: Int J Radiat Oncol Biol Phys Date: 2005-11-18 Impact factor: 7.038
Authors: Meng Law; Sarah Oh; Glyn Johnson; James S Babb; David Zagzag; John Golfinos; Patrick J Kelly Journal: Neurosurgery Date: 2006-06 Impact factor: 4.654
Authors: Tufail F Patankar; Hamied A Haroon; Samantha J Mills; Danielle Balériaux; David L Buckley; Geoff J M Parker; Alan Jackson Journal: AJNR Am J Neuroradiol Date: 2005 Nov-Dec Impact factor: 3.825
Authors: Soonmee Cha; Tarik Tihan; Forrest Crawford; Nancy J Fischbein; Susan Chang; Andrew Bollen; Sarah J Nelson; Michael Prados; Mitchel S Berger; William P Dillon Journal: AJNR Am J Neuroradiol Date: 2005-02 Impact factor: 3.825
Authors: Michael H Lev; Yelda Ozsunar; John W Henson; Amjad A Rasheed; Glenn D Barest; Griffith R Harsh; Markus M Fitzek; E Antonio Chiocca; James D Rabinov; Andrew N Csavoy; Bruce R Rosen; Fred H Hochberg; Pamela W Schaefer; R Gilberto Gonzalez Journal: AJNR Am J Neuroradiol Date: 2004-02 Impact factor: 3.825
Authors: G C Jayson; G J M Parker; S Mullamitha; J W Valle; M Saunders; L Broughton; J Lawrance; B Carrington; C Roberts; B Issa; D L Buckley; S Cheung; K Davies; Y Watson; K Zinkewich-Péotti; L Rolfe; A Jackson Journal: J Clin Oncol Date: 2004-10-04 Impact factor: 44.544
Authors: Meng Law; Jennie E Brodsky; James Babb; Marc Rosenblum; Douglas C Miller; David Zagzag; Michael L Gruber; Glyn Johnson Journal: J Magn Reson Imaging Date: 2007-06 Impact factor: 4.813
Authors: Saifee A Mullamitha; Nhuan C Ton; Geoff J M Parker; Alan Jackson; Peter J Julyan; Caleb Roberts; Gio A Buonaccorsi; Yvonne Watson; Karen Davies; Sue Cheung; Lynn Hope; Juan W Valle; John A Radford; Jeremy Lawrance; Mark P Saunders; Mihaela C Munteanu; Marian T Nakada; Jeffrey A Nemeth; Hugh M Davis; Qun Jiao; Uma Prabhakar; Zhihui Lang; Robert E Corringham; Robert A Beckman; Gordon C Jayson Journal: Clin Cancer Res Date: 2007-04-01 Impact factor: 12.531
Authors: David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues Journal: Acta Neuropathol Date: 2007-07-06 Impact factor: 17.088
Authors: S C Jung; J A Yeom; J-H Kim; I Ryoo; S C Kim; H Shin; A L Lee; T J Yun; C-K Park; C-H Sohn; S-H Park; S H Choi Journal: AJNR Am J Neuroradiol Date: 2014-01-02 Impact factor: 3.825
Authors: Jayant Narang; Rajan Jain; Ali Syed Arbab; Tom Mikkelsen; Lisa Scarpace; Mark L Rosenblum; David Hearshen; Abbas Babajani-Feremi Journal: Neuro Oncol Date: 2011-07-29 Impact factor: 12.300
Authors: Dean B Percy; Emeline J Ribot; Yuhua Chen; Catherine McFadden; Carmen Simedrea; Patricia S Steeg; Ann F Chambers; Paula J Foster Journal: Invest Radiol Date: 2011-11 Impact factor: 6.016
Authors: Julio Arevalo-Perez; Amanuel A Kebede; Kyung K Peck; Eli Diamond; Andrei I Holodny; Marc Rosenblum; Jennifer Rubel; Joshua Gaal; Vaios Hatzoglou Journal: J Neuroimaging Date: 2015-12-26 Impact factor: 2.486